Canada Pension Plan Investment Board
ELVN icon

Canada Pension Plan Investment Board’s Enliven Therapeutics ELVN Stock Holding History

Canada Pension Plan Investment Board’s Portfolio ELVN Stock Details ELVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$782K Buy
15,400
+100
+0.7% +$4.25K ﹤0.01% 1096
2026
Q1 		$600K Buy
15,300
+4,500
+42% +$125K ﹤0.01% 1176
2025
Q4 		$166K Buy
+10,800
New +$215K ﹤0.01% 1720

Other funds holding ELVN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return

Canada Pension Plan Investment Board's ELVN Position: Q2 2026 in Review

Canada Pension Plan Investment Board increased its Enliven Therapeutics (ELVN) stake by 0.65% in Q2 2026, buying an estimated $4.25K and bringing the position to 15,400 shares worth $782K. The position accounts for ﹤0.01% of the portfolio, ranked #1096.

Canada Pension Plan Investment Board first reported a position in ELVN in Q4 2025 and has held it in 3 quarters since. 212 funds tracked by Wall St. Rank hold ELVN as of Q2 2026.

  • Canada Pension Plan Investment Board held 15,400 shares of Enliven Therapeutics worth $782K as of Q2 2026.
  • Canada Pension Plan Investment Board bought 100 Enliven Therapeutics shares in Q2 2026, an estimated $4.25K.
  • Enliven Therapeutics made up ﹤0.01% of Canada Pension Plan Investment Board's portfolio in Q2 2026, its #1096 holding.
  • Canada Pension Plan Investment Board first reported a position in Enliven Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • 212 funds tracked by Wall St. Rank held Enliven Therapeutics as of Q2 2026.

Based on Canada Pension Plan Investment Board's 13F filing for Q2 2026, filed 14 Aug 2026.